WORLD
WHO Also Updates Its Recommendation on Casirivimab-imdevimab, a Monoclonal Antibody ... - Latest Tweet by World Health Organization
The latest Tweet by World Health Organization states, 'WHO also updates its recommendation on casirivimab-imdevimab, a monoclonal antibody cocktail. Based on evidence that this combination of drugs is ineffective against the Omicron, WHO now recommends that it is only given when the #COVID19 infection is caused by another variant.'
WHO also updates its recommendation on casirivimab-imdevimab, a monoclonal antibody cocktail.
Based on evidence that this combination of drugs is ineffective against the Omicron, WHO now recommends that it is only given when the #COVID19 infection is caused by another variant.— World Health Organization (WHO) (@WHO) March 3, 2022
(The above story first appeared on LatestLY on Mar 03, 2022 08:34 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
